Literature DB >> 25801876

MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.

Fei Han1, Prasad Konkalmatt2, Jianghua Chen2, John Gildea2, Robin A Felder2, Pedro A Jose2, Ines Armando2.   

Abstract

Lack or downregulation of the dopamine D2 receptor (D2R) increases the vulnerability to renal inflammation independent of blood pressure in mice. Common single nucleotide polymorphisms (SNPs) rs6276, 6277, and 1800497 in the human D2R gene are associated with decreased receptor expression/function and hypertension. Human renal proximal tubule cells from subjects carrying these SNPs have decreased D2R expression and increased expression of profibrotic factors and production of extracellular matrix proteins. We tested the hypothesis that the D2R mediates these effects by regulating micro-RNA expression. In cells carrying D2R SNPs, micro-RNAs (miRs)-217, miR-224, miR-335, and miR-1265 were downregulated, whereas miR-1290 was upregulated >4-fold compared with those carrying D2R wild-type alleles. However, only miR-217 was directly regulated by D2R expression. In cells carrying D2R wild-type, miR-217 inhibitor increased the expression of transforming growth factor (TGF)-β1, matrix metalloproteinase 3, fibronectin 1, and collagen 1a, whereas miR-217 mimic had the opposite effect. In cells carrying D2R SNPs, miR-217 mimic also decreased the expression of TGFβ1 and its targets. Wnt5a, a miR-217 target, was increased in cells carrying D2R SNPs and decreased by miR-217 mimic but increased by miR-217 inhibitor in both cell types. In cells carrying D2R wild-type, Wnt5a treatment increased TGFβ1 while silencing Ror2, a Wnt5a receptor, decreased TGFβ1 and blunted the Wnt5a-induced increase in cells carrying D2R wild-type. Our results show that renal proximal tubule cells from subjects carrying D2R SNPs resulting in D2R downregulation have increased TGFβ1 that is mediated by decreased regulation of the miR-217-Wnt5a-Ror2 pathway.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  microRNAs; receptor, dopamine D2; transforming growth factors

Mesh:

Substances:

Year:  2015        PMID: 25801876      PMCID: PMC4393363          DOI: 10.1161/HYPERTENSIONAHA.114.05096

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

1.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 2.  FibromiRs: translating molecular discoveries into new anti-fibrotic drugs.

Authors:  Nicolas Pottier; Christelle Cauffiez; Michael Perrais; Pascal Barbry; Bernard Mari
Journal:  Trends Pharmacol Sci       Date:  2014-02-19       Impact factor: 14.819

Review 3.  Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders.

Authors:  Amy J McKnight; Diane Currie; Alexander P Maxwell
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

4.  Isolation, growth, and characterization of human renal epithelial cells using traditional and 3D methods.

Authors:  John J Gildea; Helen E McGrath; Robert E Van Sciver; Dora Bigler Wang; Robin A Felder
Journal:  Methods Mol Biol       Date:  2013

5.  The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.

Authors:  Isao Oishi; Hiroaki Suzuki; Nobuyuki Onishi; Ritsuko Takada; Shuichi Kani; Bisei Ohkawara; Ikue Koshida; Kentaro Suzuki; General Yamada; Georg C Schwabe; Stefan Mundlos; Hiroshi Shibuya; Shinji Takada; Yasuhiro Minami
Journal:  Genes Cells       Date:  2003-07       Impact factor: 1.891

6.  MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.

Authors:  Hongping Xia; London Lucien P J Ooi; Kam M Hui
Journal:  Hepatology       Date:  2013-06-25       Impact factor: 17.425

7.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

8.  Critical role of CXCL16 in hypertensive kidney injury and fibrosis.

Authors:  Yunfeng Xia; Mark L Entman; Yanlin Wang
Journal:  Hypertension       Date:  2013-09-23       Impact factor: 10.190

9.  Inflammation compromises renal dopamine D1 receptor function in rats.

Authors:  Mohammad Asghar; Gaurav Chugh; Mustafa F Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30

10.  Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.

Authors:  Pushplata Prasad; K M Prasanna Kumar; A C Ammini; Arvind Gupta; Rajeev Gupta; B K Thelma
Journal:  BMC Genet       Date:  2008-03-22       Impact factor: 2.797

View more
  21 in total

1.  MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells.

Authors:  Yanlin Li; Haiwen An; Jie Pang; Lin Huang; Jinshan Li; Linna Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

Authors:  Prasad R Konkalmatt; Laureano D Asico; Yanrong Zhang; Yu Yang; Cinthia Drachenberg; Xiaoxu Zheng; Fei Han; Pedro A Jose; Ines Armando
Journal:  JCI Insight       Date:  2016-06-02

Review 3.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

4.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

5.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

Review 6.  Kidney tubules: intertubular, vascular, and glomerular cross-talk.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

7.  Non-Contingent Exposure to Amphetamine in Adolescence Recruits miR-218 to Regulate Dcc Expression in the VTA.

Authors:  Santiago Cuesta; José Maria Restrepo-Lozano; Steven Silvestrin; Dominique Nouel; Angélica Torres-Berrío; Lauren M Reynolds; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853

Review 8.  Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.

Authors:  Kirti Bhatt; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-04

9.  Dopamine reduces cell surface Na+/H+ exchanger-3 protein by decreasing NHE3 exocytosis and cell membrane recycling.

Authors:  Ming Chang Hu; I Alexandru Bobulescu; Henry Quiñones; Serge M Gisler; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-02

Review 10.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.